Ovarian cancer during pregnancy

The frequency of cancer during pregnancy is approximately 1 per 1000 live births. This rate may increase as more women postpone childbirth until later in life, when cancer becomes more frequent. Pregnancy affectsmanagement of the cancer, and the cancer affects the management of pregnancy. The most common malignancies, in order of frequency, are breast cancer, leukaemia and lymphomas as a group, melanoma, gynaecologic cancers, and bone tumours. Ovarian tumours are found in about 1 in 1000 pregnancies and 3-6% of these are malignant. Thus, ovarian cancer occurs in approximately 1 in 12,500-25,000 pregnancies. Here, we report a case of ovarian mucinous carcinoma that was diagnosed at 22 weeks of gestation. After conservative surgery, she was given three cycles of carboplatin chemotherapy. She delivered at 33 weeks of gestation and after undergoing surgery she was given six cycles of paclitaxel and carboplatin chemotherapy. The patient is now being followed by the oncology department with no evidence of disease.

Dergi Adı Journal of the Pakistan Medical Association
Dergi Cilt Bilgisi 61
Dergi Sayısı 9
Sayfalar 914 - 916
Yayın Yılı 2011
Eser Adı
[dc.title]
Ovarian cancer during pregnancy
Yazar
[dc.contributor.author]
Barut A.
Yazar
[dc.contributor.author]
Arikan I.
Yazar
[dc.contributor.author]
Barut F.
Yazar
[dc.contributor.author]
Harma M.
Yazar
[dc.contributor.author]
Harma M.I.
Yazar
[dc.contributor.author]
Payasli B.
Yayın Yılı
[dc.date.issued]
2011
Yayın Türü
[dc.type]
article
Özet
[dc.description.abstract]
The frequency of cancer during pregnancy is approximately 1 per 1000 live births. This rate may increase as more women postpone childbirth until later in life, when cancer becomes more frequent. Pregnancy affectsmanagement of the cancer, and the cancer affects the management of pregnancy. The most common malignancies, in order of frequency, are breast cancer, leukaemia and lymphomas as a group, melanoma, gynaecologic cancers, and bone tumours. Ovarian tumours are found in about 1 in 1000 pregnancies and 3-6% of these are malignant. Thus, ovarian cancer occurs in approximately 1 in 12,500-25,000 pregnancies. Here, we report a case of ovarian mucinous carcinoma that was diagnosed at 22 weeks of gestation. After conservative surgery, she was given three cycles of carboplatin chemotherapy. She delivered at 33 weeks of gestation and after undergoing surgery she was given six cycles of paclitaxel and carboplatin chemotherapy. The patient is now being followed by the oncology department with no evidence of disease.
Kayıt Giriş Tarihi
[dc.date.accessioned]
2019-12-23
Açık Erişim Tarihi
[dc.date.available]
2019-12-23
Yayın Dili
[dc.language.iso]
eng
Konu Başlıkları
[dc.subject]
Cancer
Konu Başlıkları
[dc.subject]
Ovarian tumour
Konu Başlıkları
[dc.subject]
Pregnancy
Haklar
[dc.rights]
info:eu-repo/semantics/closedAccess
ISSN
[dc.identifier.issn]
0030-9982
İlk Sayfa Sayısı
[dc.identifier.startpage]
914
Son Sayfa Sayısı
[dc.identifier.endpage]
916
Dergi Adı
[dc.relation.journal]
Journal of the Pakistan Medical Association
Dergi Sayısı
[dc.identifier.issue]
9
Dergi Cilt Bilgisi
[dc.identifier.volume]
61
Tek Biçim Adres
[dc.identifier.uri]
https://hdl.handle.net/20.500.12628/6895
Görüntülenme Sayısı ( Şehir )
Görüntülenme Sayısı ( Ülke )
Görüntülenme Sayısı ( Zaman Dağılımı )
Görüntülenme
38
09.12.2022 tarihinden bu yana
İndirme
1
09.12.2022 tarihinden bu yana
Son Erişim Tarihi
08 Şubat 2024 02:08
Google Kontrol
Tıklayınız
cancer carboplatin chemotherapy gestation cycles tumours surgery ovarian frequency pregnancy pregnancies approximately conservative report mucinous carcinoma diagnosed followed disease evidence department oncology patient paclitaxel undergoing delivered 500-25 postpone Pregnancy frequent becomes childbirth affects increase births
6698 sayılı Kişisel Verilerin Korunması Kanunu kapsamında yükümlülüklerimiz ve çerez politikamız hakkında bilgi sahibi olmak için alttaki bağlantıyı kullanabilirsiniz.

creativecommons
Bu site altında yer alan tüm kaynaklar Creative Commons Alıntı-GayriTicari-Türetilemez 4.0 Uluslararası Lisansı ile lisanslanmıştır.
Platforms